GHRP-6 vs Sermorelin
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Growth Hormone Releasing Peptide 6, SKF-110679
GHRP-6 is a synthetic six-amino-acid peptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) that tricks the body into releasing its own growth hormone. It was one of the first growth hormone secretagogues ever made, and the hunt to find out why it worked led scientists straight to the discovery of ghrelin. It has no approval as a drug anywhere and is used only as a research compound.
Also: Geref, GRF 1-29
Sermorelin is a 29-amino-acid fragment of human growth hormone-releasing hormone (GHRH), and it is the shortest piece of GHRH that still works fully. It asks the pituitary to make and release its own growth hormone rather than injecting GH itself. It was once an FDA-approved drug for diagnosing and treating growth hormone deficiency in children, but the manufacturer pulled it from the market in 2008, so today it is available mainly through compounding pharmacies for off-label use.
Key Comparison Insights
- Both peptides belong to the Growth Hormone category, suggesting similar primary applications.
- GHRP-6 has stronger research evidence (Human Trials) compared to Sermorelin (Animal Studies).
Detailed Comparison
| Attribute | GHRP-6 | Sermorelin |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | GHRP-6 binds and activates the growth hormone secretagogue receptor type 1a (GHS-R1a), the same receptor later found to be the natural target of the hunger hormone ghrelin. When it switches that receptor on in the pituitary and hypothalamus, the pituitary fires off a pulse of growth hormone. Because GHS-R1a also sits on appetite-driving neurons in the brain (the NPY/AgRP cells of the arcuate nucleus), GHRP-6 is a strong appetite stimulant, more so than the other GHRPs. At higher doses it also nudges up cortisol and prolactin, since the receptor system is not perfectly selective for the GH pathway. | Sermorelin copies the first 29 amino acids of natural GHRH and binds the GHRH receptor on the anterior pituitary, which is the body's normal on-switch for growth hormone production. Activating that receptor tells the pituitary to synthesize and release GH in pulses. A useful safety feature falls out of this design: because the pituitary still answers to its own inhibitory hormone somatostatin, the GH rise stays under negative-feedback control, which makes a true overdose of GH much harder to produce than with injected recombinant GH. |
| Common Dosing | 100-300 mcg 2-3x daily 2-3x daily | 200-500 mcg before bed Once daily, typically before bed |
| Administration | Subcutaneous injection, ideally fasted | Subcutaneous injection at bedtime |
| Typical Duration | 8-12 weeks | 3-6 months typical |
| Best Time to Take | Before bed or morning (fasted) | Before bed (fasted) |
Possible Side Effects May vary by individual |
|
|
| Research Summary | GHRP-6 has been studied in humans, but mostly as a lab and diagnostic probe rather than as a treatment with large clinical trials behind it. Early work in the 1980s and 1990s showed it reliably triggers growth hormone release, and chasing its mechanism is literally what led Kojima and colleagues to discover ghrelin in 1999, which reframed how we understand hunger and GH control. A 2013 pharmacokinetic study in nine healthy men found oral bioavailability under 1 percent and an elimination half-life around 2.5 hours, which is why it is given by injection. The popular claims about muscle gain, fat loss, and healing in fitness circles are not backed by controlled human outcome trials. It is not approved by the FDA or EMA for any use and remains a research chemical, with appetite stimulation, water retention, and cortisol/prolactin bumps as known effects. | Sermorelin has a real clinical pedigree, unlike many gray-market peptides. The FDA approved it in 1990 as a diagnostic for GH deficiency and in 1997 for treating idiopathic GH deficiency in children with growth failure, after studies showed about six months of daily injections increased GH release and growth velocity. Published work found intravenous sermorelin is a relatively specific test for GH deficiency with few false positives, and once-daily subcutaneous dosing promoted growth in some GH-deficient prepubertal children. Where the evidence gets thin is the popular adult anti-aging use: a 2006 editorial argued sermorelin is a smarter way to address age-related GH decline than recombinant GH, but it openly conceded that few long-term clinical studies exist. The drug was discontinued commercially in 2008 for business reasons, not safety, so current adult use rests on compounded product and limited modern trial data. |
Frequently Asked Questions: GHRP-6 vs Sermorelin
What is the difference between GHRP-6 and Sermorelin?
GHRP-6 is a growth hormone peptide that ghrp-6 is a synthetic six-amino-acid peptide (his-d-trp-ala-trp-d-phe-lys-nh2) that tricks the body into releasing its own growth hormone. it was one of the first growth hormone secretagogues ever made, and the hunt to find out why it worked led scientists straight to the discovery of ghrelin. it has no approval as a drug anywhere and is used only as a research compound. Sermorelin is a growth hormone peptide that sermorelin is a 29-amino-acid fragment of human growth hormone-releasing hormone (ghrh), and it is the shortest piece of ghrh that still works fully. it asks the pituitary to make and release its own growth hormone rather than injecting gh itself. it was once an fda-approved drug for diagnosing and treating growth hormone deficiency in children, but the manufacturer pulled it from the market in 2008, so today it is available mainly through compounding pharmacies for off-label use. The main differences lie in their mechanisms of action and clinical applications.
Which is better, GHRP-6 or Sermorelin?
Neither is universally "better" - the choice depends on your specific goals. GHRP-6 is typically used for growth hormone purposes, while Sermorelin is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can GHRP-6 and Sermorelin be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using GHRP-6 and Sermorelin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.